Newsletter Archive

  1. 07.06.26 -- Understanding FDA's Plausible Mechanism Framework For Genetic Medicines 7/6/2026
    07/06/26 Life Science Leader Newsletter
  2. 07.05.26 -- GLP-1 Product Development Moves Toward Niche Populations 7/5/2026
    07/05/26 Life Science Leader Newsletter
  3. 07.02.26 -- New Podcast Episodes: A Midyear Look At Life Sciences, Derisking CNS Drug Development, In Vivo Gene Editing 7/2/2026
    07/02/26 Life Science Leader Newsletter
  4. 06.29.26 -- From Clinical To Market: Managing Pharma's Most Challenging Transition 6/29/2026
    06/29/26 Life Science Leader Newsletter
  5. 06.28.26 -- Will FDA's Plausible Mechanism Framework Unleash More Cures? 6/28/2026
    06/28/26 Life Science Leader Newsletter
  6. 06.25.26 -- Smarter risk management for single-use and filtration systems. 6/25/2026
    06/25/26 Life Science Leader Newsletter
  7. 06.24.26 -- Five Ways To Unleash The Potential Of Women In STEM 6/24/2026
    06/24/26 Life Science Leader Newsletter
  8. 06.22.26 -- The State Of FDA And Global Regulations For Radiopharmaceuticals 6/22/2026
    06/22/26 Life Science Leader Newsletter
  9. 06.21.26 -- Why Do So Many New Drug Launches Fail To Meet Expectations? 6/21/2026
    06/21/26 Life Science Leader Newsletter
  10. 06.18.26 -- Reduce mAb Aggregates: Practical Strategies 6/18/2026

    06/18/26 Life Science Leader Newsletter